Clinical Trial Update: A Phase 4 Post-marketing Study of Intramuscular Injections of BLB-750 in Healthy Adult Subjects [Phase 4]

View source ↗

Summary

Phase 4 post-marketing study evaluating intramuscular injections of BLB-750 in healthy adults, completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pandemic Influenza Prevention

Drugs mentioned

• BLB-750

Snippet

Sponsor: Takeda | Conditions: Pandemic Influenza Prevention | Phase 4 | Status: COMPLETED | Results posted: 2019-07-29